Balloon catheter method for reducing restenosis via irreversible electroporation

• US 10,010,666 B2
• Filed: 06/24/2014
• Issued: 07/03/2018
• Est. Priority Date: 03/27/2008
• Status: Active Grant

• Current Assignee: AngioDynamics, Inc., Regents of the University of California (University of California)
• Original Assignee: AngioDynamics, Inc., Regents of the University of California (University of California)
• Inventors: Rubinsky, Boris, Maor, Elad, Ivorra, Antoni, Mitchell, James J., Hamilton, William C.
• Primary Examiner(s): Mehta, Bhisma
• Assistant Examiner(s): WILSON, LARRY ROSS
• Application Number:
  US14/313,647
• Publication Number:
  US 20140309579A1
• Time in Patent Office: 1,470 Days
• CPC Class Codes: A61B 18/14 Probes or electrodes therefor
• CPC Class Codes: A61B 18/1492 having a flexible, catheter-like structure, e.g. for heart ablation A61B18/1477 takes precedence
• CPC Class Codes: A61B 2017/22038 with a guide wire
• CPC Class Codes: A61B 2018/00166 Multiple lumina
• CPC Class Codes: A61B 2018/00214 Expandable means emitting energy, e.g. by elements carried thereon
• CPC Class Codes: A61B 2018/0022 Balloons
• CPC Class Codes: A61B 2018/0041 Removal of thrombosis
• CPC Class Codes: A61B 2018/00613 Irreversible electroporation
• CPC Class Codes: A61B 2018/1435 Spiral
• CPC Class Codes: A61M 5/14 Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
• CPC Class Codes: A61N 1/327 for enhancing the absorption properties of tissue, e.g. by electroporation

Abstract

Restenosis or neointimal formation may occur following angioplasty or other trauma to an artery such as by-pass surgery. This presents a major clinical problem which narrows the artery. The invention provides a balloon catheter with a particular electrode configuration. Also provided is a method whereby vascular cells in the area of the artery subjected to the trauma are subjected to irreversible electroporation which is a non-thermal, non-pharmaceutical method of applying electrical pulses to the cells so that substantially all of the cells in the area are ablated while leaving the structure of the vessel in place and substantially unharmed due to the non-thermal nature of the procedure.

Claims

1. A method of treatment, comprising:

ablating tissue cells in a blood vessel with a balloon catheter comprised of;

a flexible elongated shaft comprising a distal end portion for insertion into a vessel;

a balloon positioned at the distal end portion;

a first electrode positioned at the distal end portion of the shaft, the first electrode being comprised of a conductive material which is flexible and generally conforms to an outer surface of the balloon during expansion of the balloon;

a second electrode positioned at a point relative to the first electrode so as to allow electrical current to flow through vascular tissue between the first and second electrodes, the second electrode being comprised of a conductive material which is flexible and conforms to the outer surface of the balloon during expansion of the balloon, wherein the first electrode and second electrode are positioned in an overlapping relationship on a single longitudinal axis to form a double helix spanning an entire length of the balloon, and comprising multiple helical turns around the balloon, and wherein the first and second electrodes are positioned to generate an electric field encompassing substantially the entire outer balloon surface;

an electrical power source which provides electrical pulses to the electrodes in amounts sufficient to subject substantially all vascular tissue cells in a target area of the vessel to non-thermal irreversible electroporation (NTIRE);

whereby the step of ablating is carried out by providing the electrical pulses to the first and second electrodes.

2. The method of claim 1, wherein the first and second electrodes comprise electrically conductive ink drawn on the balloon whereby the pulses are provided for durations and in amounts sufficient to subject substantially all vascular cells in a target area to irreversible electroporation (IRE).

3. The method of claim 1, wherein the electrical power source is designed such that the IRE is carried out using a voltage and a current with defined ranges over a defined period of time and in absence of drug being delivered into the vascular tissue cells.

4. The method of claim 1, wherein the electrical pulses each have a pulse duration of from 50 to 200 microseconds.

5. The method of claim 1, wherein the electrical pulses are direct current pulses.

6. The method of claim 5, wherein the electrical pulses each have a pulse duration of from 50 to 200 microseconds.

7. The method of claim 6, wherein the electrical power source is configured to apply the electrical pulses of a current at a voltage in a range of from 2,000 V/cm to 6,000 V/cm.

8. The method of claim 7, wherein the electrical power source is configured to apply between two and twenty-five pulses.

9. A method of treatment, comprising:

ablating tissue cells in a blood vessel with a balloon catheter comprised of;

a flexible elongated shaft comprising a distal end portion for insertion into a vessel;

a balloon positioned at the distal end portion;

a first electrode positioned at the distal end portion of the shaft, the first electrode being comprised of a conductive material which is flexible and generally conforms to an outer surface of the balloon during expansion of the balloon;

a second electrode positioned at a point relative to the first electrode so as to allow electrical current to flow through vascular tissue between the first and second electrodes, the second electrode being comprised of a conductive material which is flexible and conforms to the outer surface of the balloon during expansion of the balloon, wherein the first electrode and second electrode are positioned in an overlapping relationship on a single longitudinal axis to form a double helix spanning an entire length of the balloon, and comprising multiple helical turns around the balloon, and wherein the first and second electrodes are positioned to generate an electric field encompassing substantially the entire outer balloon surface;

an electrical power source which provides electrical pulses to the electrodes in amounts sufficient to subject substantially all vascular tissue cells in a target area of the vessel to non-thermal irreversible electroporation (NTIRE);

wherein the first and second electrodes comprise electrically conductive ink drawn on the balloon;

wherein the electrical power source is configured to apply the electrical pulses having a pulse duration of from 50 to 200 microseconds;

wherein the electrical power source is configured to apply the electrical pulses of a current at a voltage in a range of from 2,000 V/cm to 6,000 V/cm.

10. A method of treatment, comprising:

ablating tissue cells in a blood vessel with a balloon catheter comprised of;

a flexible elongated shaft comprising a distal end portion for insertion into a vessel;

a balloon comprising a proximal balloon neck and a distal balloon neck, the balloon positioned at the distal end portion;

a first electrode comprising a distal collar coaxially surrounding the distal balloon neck, the first electrode positioned at the distal end portion of the shaft, the first electrode being comprised of a conductive material which is flexible and generally conforms to an outer surface of the balloon during expansion of the balloon;

a second electrode comprising a proximal collar coaxially surrounding the proximal balloon neck, the second electrode positioned at a point relative to the first electrode so as to allow electrical current to flow through vascular tissue between the first and second electrodes, the second electrode being comprised of a conductive material which is flexible and conforms to the outer surface of the balloon during expansion of the balloon, wherein the first electrode and second electrode are positioned in an overlapping relationship on a single longitudinal axis to form a double helix comprising multiple helical turns around the balloon, and wherein the first and second electrodes are positioned to generate an electric field encompassing substantially the entire outer balloon surface;

an electrical power source which provides electrical pulses to the electrodes in amounts sufficient to subject substantially all vascular tissue cells in a target area of the vessel to non-thermal irreversible electroporation (NTIRE);

whereby the step of ablating is carried out by providing the electrical pulses to the first and second electrodes.

11. The method of claim 10, wherein the first and second electrodes comprise electrically conductive ink drawn on the balloon whereby the pulses are provided for durations and in amounts sufficient to subject substantially all vascular cells in a target area to irreversible electroporation (IRE).

12. The method of claim 10, wherein the electrical power source is designed such that the IRE is carried out using a voltage and a current with defined ranges over a defined period of time and in absence of drug being delivered into the vascular tissue cells.

13. The method of claim 10, wherein the electrical pulses each have a pulse duration of from 50 to 200microseconds.

14. The method of claim 10, wherein the electrical pulses are direct current pulses.

15. The method of claim 14, wherein the electrical pulses each have a pulse duration of from 50 to 200 microseconds.

16. The method of claim 15, wherein the electrical power source is configured to apply the electrical pulses of a current at a voltage in a range of from 2,000 V/cm to 6,000 V/cm.

17. The method of claim 16, wherein the electrical power source is configured to apply between two and twenty-five pulses.

18. A method of treatment, comprising:

ablating tissue cells in a blood vessel with a balloon catheter comprised of;

a flexible elongated shaft comprising a distal end portion for insertion into a vessel;

a balloon comprising a proximal balloon neck and a distal balloon neck, the balloon positioned at the distal end portion;

a first electrode comprising a distal collar coaxially surrounding the distal balloon neck, the first electrode positioned at the distal end portion of the shaft, the first electrode being comprised of a conductive material which is flexible and generally conforms to an outer surface of the balloon during expansion of the balloon;

a second electrode comprising a proximal collar coaxially surrounding the proximal balloon neck, the second electrode positioned at a point relative to the first electrode so as to allow electrical current to flow through vascular tissue between the first and second electrodes, the second electrode being comprised of a conductive material which is flexible and conforms to the outer surface of the balloon during expansion of the balloon, wherein the first electrode and second electrode are positioned in an overlapping relationship on a single longitudinal axis to form a double helix comprising multiple helical turns around the balloon, and wherein the first and second electrodes are positioned to generate an electric field encompassing substantially the entire outer balloon surface;

an electrical power source which provides electrical pulses to the electrodes in amounts sufficient to subject substantially all vascular tissue cells in a target area of the vessel to non-thermal irreversible electroporation (NTIRE);

wherein the first and second electrodes comprise electrically conductive ink drawn on the balloon;

wherein the electrical power source is configured to apply the electrical pulses having a pulse duration of from 50 to 200 microseconds;

wherein the electrical power source is configured to apply the electrical pulses of a current at a voltage in a range of from 2,000 V/cm to 6,000 V/cm.